TESTOSTERONE IS A KEY RISK FACTOR FOR NONALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN YOUNG PRE-MENOPAUSAL WOMEN WITH FATTY LIVER

被引：0

作者：

Sarkar, Monika ^{[1
]}

Suzuki, Ayako ^{[2
]}

Abdelmalek, Manal F. ^{[3
]}

Bass, Nathan M. ^{[1
]}

Wilson, Laura ^{[4
]}

Yates, Katherine ^{[5
]}

Cedars, Marcelle ^{[6
]}

Gill, Ryan ^{[7
]}

Terrault, Norah ^{[8
]}

机构：

[1] UCSF, Med GI Hepatol, San Francisco, CA USA

[2] Duke Univ, Gastroenterol, Durham VA Med Ctr, Durham, NC 27706 USA

[3] Duke Univ, Gastroenterol, Durham, NC 27706 USA

[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA

[5] Johns Hopkins, Baltimore, MD USA

[6] Univ Calif San Francisco, Obstet & Gynecol, San Francisco, CA 94143 USA

[7] Univ Calif San Francisco, Pathol, San Francisco, CA 94143 USA

[8] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1638

引用

页码：996 / 997

页数：2

共 50 条

[31] COMMON GENETIC POLYMORPHISMS ASSOCIATED WITH ADVANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C ARE ASSOCIATED WITH RISK OF NONALCOHOLIC STEATOHEPATITIS AND CIRRHOSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE [J].

Bambha, Kiran ;

Abar, Olivia ;

Chang, Monica ;

Schrodi, Steven J. ;

Ross, David A. ;

Catanese, Joe ;

Lagier, Robert J. ;

Rawland, Charles M. ;

Merriman, Raphael B. ;

Aouizerat, Bradley E. ;

Sninsky, John ;

Bass, Nathan M. .

HEPATOLOGY, 2008, 48 (04) :815A-816A

[32] A Longer Duration of Estrogen Deficiency Increases Fibrosis Risk Among Postmenopausal Women With Nonalcoholic Fatty Liver Disease [J].

Klair, Jagpal Singh ;

Yang, Ju Dong ;

Abdelmalek, Manal F. ;

Guy, Cynthia D. ;

Gill, Ryan M. ;

Yates, Katherine ;

Unalp-Arida, Aynur ;

Lavine, Joel E. ;

Clark, Jeanne M. ;

Diehl, Anna Mae ;

Suzuki, Ayako .

HEPATOLOGY, 2016, 64 (01) :85-91

[33] A large waist circumference is associated with higher liver fat in healthy pre-menopausal women in the absence of classical biochemical risk factors for CVD [J].

Hodson, L. ;

Banerjee, R. ;

Cheeseman, J. ;

Karpe, F. ;

Fielding, B. A. .

PROCEEDINGS OF THE NUTRITION SOCIETY, 2011, 70 (OCE4) :E229-E229

[34] DIAGNOSTIC PERFORMANCE OF METABOLOMIC TEST TO DETECT NONALCOHOLIC STEATOHEPATITIS AND SIGNIFICANT FIBROSIS IN PATIENTS AT HIGH RISK OF PROGRESSIVE FATTY LIVER DISEASE. [J].

Mayo, Rebeca ;

Iruzubieta, Paula ;

Minchole, Itziar ;

Aller, Rocio ;

Samaniego, Luis Ibanez ;

Herrojo, Javier Ampuero ;

Abad, Javier ;

Mateos, Rosa Martin ;

Arias, Maria Teresa ;

Albillos, Agustin ;

Banares, Rafael ;

Panero, Jose Luis Calleja ;

Romero-Gomez, Manuel ;

Ortiz, Pablo ;

Martinez-Arranz, Ibon ;

Garcia, Javier Crespo .

HEPATOLOGY, 2021, 74 :949A-950A

[35] Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study [J].

Nabi, Oumarou ;

Lacombe, Karine ;

Boursier, Jerome ;

Mathurin, Philippe ;

Zins, Marie ;

Serfaty, Lawrence .

GASTROENTEROLOGY, 2020, 159 (02) :791-+

[36] Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III [J].

Decker, Rourke D. ;

Ghiraldi, Eric M. ;

Weiss, Alexandra H. ;

Gaughan, John P. ;

Friedlander, Justin I. .

JOURNAL OF ENDOUROLOGY, 2020, 34 (12) :1258-1262

[37] Fibrosis-4 Score (FIB-4) Provides Consistent Assessment of Healthcare Costs and Healthcare Resource Utilization (HCRU) Among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis [J].

Gordon, Stuart C. ;

Ozbay, Burak ;

Parker, Emily ;

Korrer, Stephanie ;

Wong, Robert J. .

HEPATOLOGY, 2018, 68 :617A-618A

[38] No effect of epigallocatechin-3-gallate with weight loss on adiposity reduction, cardiometabolic risk factors and liver function in pre-menopausal obese women [J].

Kawada, Tomoyuki .

BRITISH JOURNAL OF NUTRITION, 2014, 112 (09) :1586-1586

[39] Increased Health-Care Resource Utilization (HRU) and Costs among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis (AF) having Diabetes Mellitus (DM) [J].

Gordon, Stuart ;

Kachru, Nandita ;

Ozbay, A. Burak ;

Wong, Robert .

DIABETES, 2019, 68

[40] High Risk of Nonalcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH) in Obese Patients with Type 2 Diabetes Mellitus (T2DM) and Normal Liver Aminotransferases [J].

Maximos, Maryann ;

Bril, Fernando ;

Sanchez, Paola Portillo ;

Lomonaco, Romina ;

Biernacki, Diane ;

Subbarayan, Sreevidya ;

Suman, Amitabh ;

Cusi, Kenneth .

DIABETES, 2014, 63 :A464-A464

← 1 2 3 4 5 →